GUFICBIO Intraday Analysis...

GUFICBIO Share Price

Open 128.40 Change Price %
High 138.75 1 Day 1.20 0.95
Low 126.50 1 Week -0.65 -0.51
Close 128.05 1 Month 16.80 15.10
Volume 1079687 1 Year 73.95 136.69
52 Week High 144.35
52 Week Low 54.10
GUFICBIO Important Levels
Resistance 2 139.41
Resistance 1 134.73
Pivot 131.10
Support 1 121.37
Support 2 116.69
NSE INDIA Most Active Stocks
GMRINFRA 22.75 -5.60%
RCOM 29.35 -9.27%
JPASSOCIAT 20.85 -8.55%
VISESHINFO 0.30 0.00%
UNITECH 8.80 -6.38%
ADANIPOWER 36.95 -9.33%
GAMMNINFRA 3.85 -14.44%
SUZLON 14.85 -3.26%
SBIN 303.25 -1.25%
YESBANK 341.20 -0.35%
More..
NSE INDIA Top Gainers Stocks
ZENITHBIR 0.50 11.11%
NAKODA 0.55 10.00%
PGEL 443.15 9.96%
HINDSYNTEX 12.35 9.78%
MINDTREE 684.15 9.49%
GRUH 598.10 8.38%
ZYLOG 4.40 7.32%
EXCELCROP 3295.30 7.28%
SPYL 0.75 7.14%
RAJRAYON 0.80 6.67%
More..
NSE INDIA Top Losers Stocks
GAMMNINFRA 3.85 -14.44%
JUSTDIAL 557.65 -12.24%
KSERASERA 0.40 -11.11%
IMPAL 1173.25 -10.35%
SHEMAROO 499.10 -9.34%
ADANIPOWER 36.95 -9.33%
RCOM 29.35 -9.27%
SYNCOM 6.90 -9.21%
SANCO 45.40 -8.56%
JPASSOCIAT 20.85 -8.55%
More..

Gufic Biosciences Limited (NSE: GUFICBIO)

GUFICBIO Technical Analysis 4
As on 18th Jan 2018 GUFICBIO Share Price closed @ 128.05 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 79.14 & Buy for SHORT-TERM with Stoploss of 107.70 we also expect STOCK to react on Following IMPORTANT LEVELS.
GUFICBIO Target for January
1st Target up-side 150.4
2nd Target up-side 166.98
3rd Target up-side 183.56
1st Target down-side 103.1
2nd Target down-side 86.52
3rd Target down-side 69.94
GUFICBIO Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 57.62 Sideways
MFI (14) MFI is 69.09 Sideways
CCI (20) CCI is 32.24 Sideways
WILLIAM %R (14) William %R is -71.81 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 143.06
10 Day Avg Volume Traded 370.30 % More then 10 Day Average Volume
GUFICBIO Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.guficbio.com
GUFICBIO Address
GUFICBIO
Kamala Bhavan II
Shop - 37, First Floor
Mumbai, 400069
India
GUFICBIO Latest News
Limited Review for Dec 31, 2014   Hindu Business Line   - 03rd Mar 15
Proposed Bank Strikes   Hindu Business Line   - 17th Feb 15
Gufic Bio standalone Dec '14 sales at Rs 34.34 crore   Moneycontrol.com   - 17th Feb 15
BSE Breaches 25.8k Mark; Metals, Goods, Auto and Power Stocks Fall   International Business Times, India Edition   - 04th Jul 14
NPPA sends notices in 89 cases of overcharging to recover   pharmabiz.com   - 22nd Apr 14
Gufic BioSciences Ltd Recommends Dividend   Reuters Key Development   - 31st May 13
Cops hunt for fake drug maker   Times of India   - 24th Feb 09
Interactive Technical Analysis Chart Gufic Biosciences Limited ( GUFICBIO NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Gufic Biosciences Limited
GUFICBIO Business Profile
Gufic Biosciences (GUFICBIO) is a pharmaceuticals and biosciences company. Incorporated in 1984 as Central Finance, the company got its current name on Jun. 05, 2000. The company operates in the segments of pharma, healthcare, bio-technology, seeds, herbal, R&D, and bulk drugs. The company provides pharma medicines for diarrhoea (Ridol), episiotomy (Zad-g), anemia (Optifer), infections (Lotril), inflammation (Valsafe)...etc. The healthcare segment provides consumer and personal hygiene products like roll-ons for cold and sanitary napkins like Shapers. The biotechnology segment produces high-yielding and elite planting material of medicinal and other herbal plants using tissue culture techniques. The tissue culture facility produces five million plants per annum. The company has two green houses of 800 sq. m. Production includes banana, potato, sugarcane, date palm, jatropha, and bixa (source of natural food color). It brings out hybrid varieties of major vegetable seeds like tomato, chilli, cabbage, cauliflower, capsicum, coriander, bhendi, bottle gourd, bitter gourd, ridge gourd, brinjal, cucumber and watermelon. The company provides herbal and ayurvedic medicines for muscular pains (Sallaki); menstrual excesses (Eugynin); hyperacidity, gastritis, and chronic fungal dyspepsia (Zulcer), aches and pains (Rumastal-forte), liver problems (Livpar), constipation (Laxive), and cough (Kofend Syrup). Bulk drugs include anesthetics (lidocaine), antifungals (econazole, miconazole, ketokonazole), antiielmintic (mebendazole, polymorph), cathartic (castor oil), and food colors. The company has its facilities in Vile Parle, Mumbai and a plant in Navsari, Gujarat. The R&D Centre is a state-of-the-art research laboratory and provides total product development by developing new pharmaceutical products, new drug delivery systems, and new platform technologies. The functional areas are formulation development, analytical development, packaging development and documentation. The current market capitalization stands at Rs 44.48 crore. The company has reported a standalone sales of Rs 29.03 crore and a Net Profit of Rs 1.15 crore for the quarter ended September 2013. The company management includes Jayesh P Choksi - Chairman & Managing Director, Pranav J Choksi - Executive & Wholetime Director, M G Dhapalapur - Executive & Wholetime Director, Sharat S Gandhi - Ind. Non-Executive Director, Ashok M Tarale - Ind. Non-Executive Director, Khantilal N Sanghavi - Ind. Non-Executive Director, Pankaj J Gandhi - Additional Director, Jagdish D Shah - Additional Director. The Registered office is at Shop - 37, First Floor, Kamala Bhavan II, Swami Nityanand Road, Mumbai, Maharashtra - 400069.